|
|
 |
 |
 |
 |
Male Pattern Hair Loss (MPH)
Reversa
|
 Transmed Research team observed that hair loss stopped transiently in the first three weeks in patients treated with Reversa system and the hair in the region where the application was performed gained volume in three months (1). If Reversa is performed in association with vitamin supplements which accelerates restoration of lost hair, the outcome will be more satisfactory.
What is reversa?
Reversa system is application of the mixture of “Platalet rich plasma fluid” (PRP) and thrombocyte derived autologous protein in the region where the hair is thinned.
Why Reversa?
In contrast to the other PRP applications, Reversa is a procedure performed by Transmed under guidance of hematologists,
biologists and specialists physicians in the laboratory setting. Reversa system is based on FDA approved applications (in foreign medical literature) and the results of observations made by Transmed R& team.
Can Reversa be applicated in anyone?
Reversa system can be performed in men or women whose hair are thinned due to genetic or seasonal reasons, but not fully lost. Very successful results are obtained also in regional hair loss which is called ‘ALOPECIA AREATA’ in medical literature.
What is the procedure in Reversa system?
Reversa system is application of the thrombocyteswhich are obtained from your own blood to the scalp by activating with proteins which are again obtained from your own thrombocytes. It is completely prepared with your own blood.
Hair root map: Map of the hair roots in the donor region and the hair roots which have entered “miniaturization” cycle (the diameter starts to get narrow in this cycle).
With the help of the map it is determined if the patient is appropriate for Reversa and the region of the application is determined.
 30 cc of blood is obtained from the patient to prepare “Platelet-rich plasma”. This is about the same amount of blood which is taken for any blood test. The blood sample is centrifuged for a certain time in the centrifuge device with a special set and is separated into its components. The platelets obtained here is activated by a sterile process and prepared to apply to the scalp.
The Reversa cocktail is applied on the scalp with spaces of 1 cm2 with superficial injection technique and then the remaining is sprayed in the application region in the spray format.
The region of application is not washed in the first 24 hours. During this time period, mild pain is expected due to injections. However, it disappears in two hours after application. Since the Reversa cocktail does not contain anything else but the mixture of your own blood and natural protein, there is no risk of allergic reaction or infection after treatment.
You can make appointments with our physicians todiscuss the procedure.
What are the side effects of the Reversa system?
Since the Reversa mixture is composed of natural activators obtained from the patient’s own blood, there is no risk of allergic reaction or infection during the procedure or after the procedure.
What is PRP used in the Reversa system?
PRP (Platelet-rich plasma) which is used in the Reversa system and constitutes the backbone of the application is a blood side product used to accelerate wound healing since 1970s worldwide. Administration of PRP in star athletes and baseball players in USA especially in the last decade has rendered PRP a recognized treatment method in the community.
Please click here for the article of New York Times on the subject.
Is the Reversa system proved?
PRP is approved by FDA, i.e. State-Owned Food and Drug Administration, in USA. In addition, activators and proteins released from the thrombocytes used in the Reversa system are autologous (produced from the patient’s own blood and given to the patient himself/herself). There are many studies in the medical literature suggesting that these activators help cell growth.
The effects of the Reversa system may show difference in different patients. Therefore expectations should be reasonable and it should be kept in mind that the positive effects of treatment will not be at the same level in all patients.
[1] Our research team consists of one Professor of biology, one Professor of medicine, one laboratory assistant and two specialist physicians. The text of our continuing study has been presented for ethics committee approval.
|
|
 |
 |
 |
|
